Accéder au contenu
Merck

Methimazole embryopathy: delineation of the phenotype.

American journal of medical genetics (1999-03-17)
M Clementi, E Di Gianantonio, E Pelo, I Mammi, R T Basile, R Tenconi
RÉSUMÉ

We report on a further case of congenital anomalies in a child exposed to methimazole during the first trimester of pregnancy (from first to seventh gestational week), and define a specific malformation pattern related to prenatal methimazole exposure and consisting of choanal and esophageal atresia, scalp defects, minor facial anomalies and psychomotor delay.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
2-Mercapto-1-methylimidazole, ≥99%
USP
Methimazole, United States Pharmacopeia (USP) Reference Standard
Supelco
Methimazole, analytical standard
Supelco
Methimazole, VETRANAL®, analytical standard
Methimazole, European Pharmacopoeia (EP) Reference Standard